DWTX logo
DWTX NASDAQ US

Dogwood Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Dec 2020
$2.11
▼ $-0.02 (-0.94%)
Vol 19K
3
Quality Score
fail
Mkt Cap
$123.7M
ROE
-49.8%
D/E
0.00
Beta
1.87
52W
$2–$29

Wall Street Consensus

8 analysts · Apr 2026
2
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating

Price Chart

Earnings

Beat rate: 20.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-1.18 $-0.07 +$1.11
Sep 2025 $-1.25 $-8.20 $-6.95
Jun 2025 $-1.94 $-1.99 $-0.05
Mar 2025 $-2.42 $-4.19 $-1.77

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -42.9% -42.9% -42.9% -42.9% -42.9% -49.8%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 7.80 7.80 7.80 7.80 7.80 4.49

Key Ratios

ROA (TTM)
-40.2%
P/B
0.0
EPS (TTM)
$-23.66
52W High
$29.28
52W Low
$1.87
$1.87 52-Week Range $29.28

How does DWTX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

DWTX AAPG ABEO ABOS ABP

DWTX valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.1
98% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

DWTX profitability vs Biotechnology peers

ROE
-49.8%
26% above peers (-67.3%)
vs Peers
vs Industry
Below avg
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-40.2%
14% above peers (-46.7%)
vs Peers
vs Industry
In line

DWTX financial health vs Biotechnology peers

D/E ratio
0.0
0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
4.5
1% above peers (4.4)
vs Peers
vs Industry
In line
Beta
1.9
93% above peers (1.0)
vs Peers
vs Industry
More volatile

DWTX fundamentals radar

DWTX Peer median Industry

DWTX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

DWTX vs peers: key metrics

Latest News

No related news yet